Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04779151
Title	Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab (NIRADO)
Acronym	NIRADO
Recruitment	Suspended
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Gustave Roussy, Cancer Campus, Grand Paris
Indications	biliary tract cancer head and neck cancer clear cell renal cell carcinoma gastroesophageal junction adenocarcinoma bladder urothelial carcinoma gastric adenocarcinoma Advanced Solid Tumor
Therapies	Dostarlimab-gxly + Niraparib
Age Groups:	adult \| senior
Covered Countries	FRA